financetom
Business
financetom
/
Business
/
Pony AI Begins Mass Production, Road Testing of Gen-7 Robotaxis
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pony AI Begins Mass Production, Road Testing of Gen-7 Robotaxis
Jul 10, 2025 2:29 AM

05:09 AM EDT, 07/10/2025 (MT Newswires) -- Pony AI (PONY) said Thursday it has started mass production and road testing of its Gen-7 robotaxis, aiming to boost its fleet to more than 1,000 vehicles by the end of the year.

Road testing began in Guangzhou and Shenzhen, a shift from controlled environments to public traffic, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Femasys Secures CE Mark Approvals for Four Women's Health Products; Shares Up Over 14%
Femasys Secures CE Mark Approvals for Four Women's Health Products; Shares Up Over 14%
Jun 20, 2024
09:45 AM EDT, 06/20/2024 (MT Newswires) -- Femasys ( FEMY ) said Thursday it received CE Mark certifications for four of its women's health products, certifying that the products comply with new European Union regulations for medical devices. The company said the CE Mark approvals come on the heels of the products' European Union Medical Device Regulation certificates and will...
LanzaTech Global Increases Stake in LanzaJet to 36% From 23%
LanzaTech Global Increases Stake in LanzaJet to 36% From 23%
Jun 20, 2024
09:50 AM EDT, 06/20/2024 (MT Newswires) -- LanzaTech Global ( LNZA ) said Thursday that it has increased its stake in LanzaJet, a sustainable aviation fuel technology provider and fuels producer, to 36% from 23%. LanzaTech said the move is in accordance with a previous agreement that allowed LanzaJet to further sublicense the alcohol-to-jet technology developed by LanzaTech and others...
Corus Downgraded by S&P on Loss of Warner Bros. Discovery Content
Corus Downgraded by S&P on Loss of Warner Bros. Discovery Content
Jun 20, 2024
09:46 AM EDT, 06/20/2024 (MT Newswires) -- S&P Global Ratings on Wednesday downgraded its issuer credit rating on Corus Entertainment (CJR-B.TO) to B- from B+ after the company this month said some of its programming and trademark output arrangements with Warner Bros. Discovery will not be renewed when they expire on Dec. 31. The negative outlook reflects the overarching risks...
ImmunityBio's Bladder Cancer Treatment Anktiva Launches in US
ImmunityBio's Bladder Cancer Treatment Anktiva Launches in US
Jun 20, 2024
09:45 AM EDT, 06/20/2024 (MT Newswires) -- ImmunityBio ( IBRX ) said Thursday that it has launched Anktiva, its immunotherapy to treat Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer, with multiple patients across the US receiving the initial commercial doses. The US Food and Drug Administration approved Anktiva in April to treat patients with BCG-unresponsive non-muscle invasive bladder cancer with or...
Copyright 2023-2026 - www.financetom.com All Rights Reserved